XML 41 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Shareholders' Equity Statement - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-Controlling Interests
Balance, beginning of period at Dec. 31, 2017 $ 2,857.6 $ 1.2 $ 3,302.6 $ 2,713.0 $ (288.2) $ (2,953.7) $ 82.7
Balance, beginning of period (in shares) at Dec. 31, 2017   116,303,729          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 97.0     97.0      
Other comprehensive income (loss) 39.4       39.4    
Issuances under equity plans (13.8)   2.9     (16.7)  
Issuances under equity plans (in shares)   437,703          
Share-based compensation expense 7.5   7.5        
Repurchases of common stock (50.1)         (50.1)  
Noncontrolling interest transactions 1.4   0.3       1.1
Balance, end of period at Mar. 31, 2018 2,939.0 $ 1.2 3,313.3 2,825.3 (264.1) (3,020.5) 83.8
Balance, end of period (in shares) at Mar. 31, 2018   116,741,432          
Balance, beginning of period at Dec. 31, 2017 2,857.6 $ 1.2 3,302.6 2,713.0 (288.2) (2,953.7) 82.7
Balance, beginning of period (in shares) at Dec. 31, 2017   116,303,729          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (loss) (89.7)            
Balance, end of period at Sep. 30, 2018 2,810.2 $ 1.2 3,326.9 3,060.7 (393.2) (3,270.1) 84.7
Balance, end of period (in shares) at Sep. 30, 2018   116,787,320          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain reclassified due to new accounting guidance on investments       15.3 (15.3)    
Balance, beginning of period at Mar. 31, 2018 2,939.0 $ 1.2 3,313.3 2,825.3 (264.1) (3,020.5) 83.8
Balance, beginning of period (in shares) at Mar. 31, 2018   116,741,432          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 143.4     143.4      
Other comprehensive income (loss) (111.8)       (111.8)    
Issuances under equity plans (0.6)   (0.1)     (0.5)  
Issuances under equity plans (in shares)   36,792          
Share-based compensation expense 5.3   5.3        
Dividends (66.0)     (66.0)      
Repurchases of common stock (63.1)         (63.1)  
Noncontrolling interest transactions 1.3   1.6       (0.3)
Balance, end of period at Jun. 30, 2018 2,847.5 $ 1.2 3,320.1 2,902.7 (375.9) (3,084.1) 83.5
Balance, end of period (in shares) at Jun. 30, 2018   116,778,224          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 158.0     158.0      
Other comprehensive income (loss) (17.3)       (17.3)    
Issuances under equity plans 0.1   0.1        
Issuances under equity plans (in shares)   9,096          
Share-based compensation expense 6.7   6.7        
Repurchases of common stock (186.0)         (186.0)  
Noncontrolling interest transactions 1.2           1.2
Balance, end of period at Sep. 30, 2018 2,810.2 $ 1.2 3,326.9 3,060.7 (393.2) (3,270.1) 84.7
Balance, end of period (in shares) at Sep. 30, 2018   116,787,320          
Balance, beginning of period at Dec. 31, 2018 2,698.5 $ 1.2 3,337.5 3,157.7 (399.8) (3,471.7) 73.6
Balance, beginning of period (in shares) at Dec. 31, 2018   116,795,899          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 53.5     53.5      
Other comprehensive income (loss) (2.0)       (2.0)    
Issuances under equity plans (4.9)   0.4     (5.3)  
Issuances under equity plans (in shares)   247,325          
Share-based compensation expense 4.6   4.6        
Repurchases of common stock (101.0)         (101.0)  
Noncontrolling interest transactions 1.2   0.5       0.7
Balance, end of period at Mar. 31, 2019 2,649.9 $ 1.2 3,343.0 3,211.2 (401.8) (3,578.0) 74.3
Balance, end of period (in shares) at Mar. 31, 2019   117,043,224          
Balance, beginning of period at Dec. 31, 2018 2,698.5 $ 1.2 3,337.5 3,157.7 (399.8) (3,471.7) 73.6
Balance, beginning of period (in shares) at Dec. 31, 2018   116,795,899          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (loss) (52.7)            
Balance, end of period at Sep. 30, 2019 2,716.1 $ 1.2 3,361.0 3,419.4 (452.5) (3,631.0) 18.0
Balance, end of period (in shares) at Sep. 30, 2019   117,177,349          
Balance, beginning of period at Mar. 31, 2019 2,649.9 $ 1.2 3,343.0 3,211.2 (401.8) (3,578.0) 74.3
Balance, beginning of period (in shares) at Mar. 31, 2019   117,043,224          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 127.3     127.3      
Other comprehensive income (loss) (14.7)       (14.7)    
Issuances under equity plans 2.0   3.9     (1.9)  
Issuances under equity plans (in shares)   120,244          
Share-based compensation expense 8.3   8.3        
Dividends (65.2)     (65.2)      
Noncontrolling interest transactions (13.1)   (0.8)       (12.3)
Balance, end of period at Jun. 30, 2019 2,694.5 $ 1.2 3,354.4 3,273.3 (416.5) (3,579.9) 62.0
Balance, end of period (in shares) at Jun. 30, 2019   117,163,468          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 146.1     146.1      
Other comprehensive income (loss) (36.0)       (36.0)    
Issuances under equity plans 0.6   0.7     (0.1)  
Issuances under equity plans (in shares)   13,881          
Share-based compensation expense 5.9   5.9        
Repurchases of common stock (51.0)         (51.0)  
Noncontrolling interest transactions (44.0)           (44.0)
Balance, end of period at Sep. 30, 2019 $ 2,716.1 $ 1.2 $ 3,361.0 $ 3,419.4 $ (452.5) $ (3,631.0) $ 18.0
Balance, end of period (in shares) at Sep. 30, 2019   117,177,349